SG/PUT/DANAHER/260/0.1/19.07.24 Share Price

Warrant

DE000SY0ZD52

Market Closed - Boerse Frankfurt Warrants 20:46:08 28/06/2024 BST
1.18 EUR +19.19% Intraday chart for SG/PUT/DANAHER/260/0.1/19.07.24
Current month+6.25%
1 month+100.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 1.02 +3.03%
27/06/24 0.99 +20.73%
26/06/24 0.82 -1.20%
25/06/24 0.83 +16.90%
24/06/24 0.71 -23.66%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 08:46 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying DANAHER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SY0ZD5
ISINDE000SY0ZD52
Date issued 28/05/2024
Strike 260 $
Maturity 19/07/2024 (20 Days)
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.34
Lowest since issue 0.37
Delta-0.73x
Omega 15.09
Premium0.78x
Gearing20.64x
Moneyness 1.041
Difference Strike 10.15 $
Difference Strike %+3.90%
Spread 0.02
Spread %1.75%
Theoretical value 1.120
Implied Volatility 24.38 %
Total Loss Probability 25.01 %
Intrinsic value 0.9477
Present value 0.1723
Break even 248.00 €
Theta-0.07x
Vega0.02x
Rho-0.01x

Company Profile

Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Sector
-
More about the company

Ratings for Danaher Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Danaher Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
249.8 USD
Average target price
273.3 USD
Spread / Average Target
+9.39%
Consensus